Equity
€42,251 ▲ 26.3%
DOCSTEPH paid out €15,000 in dividends. That is 63% of the 2025 profit.
DOCSTEPH
Overview
Lifetime
3 annual accounts with figures on one time axispeak €57,320 (2024)
€52,749▼ 8.0%
peak €27,785 (2024)
€23,795▼ 14.4%
peak €42,251 (2025)
€42,251▲ 26.3%
€42,356▼ 40.1%
Board1 name since 2023
1 director
Documentsfilings and deeds
14-07-202617 days before the deadline
2025micro format
Dividend €15,000Equity from €33,456 to €42,251Debts from €70,673 to €42,356
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,274 companies had the same profile as DOCSTEPH has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,274 companies, not a prediction for DOCSTEPH. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director
- 90 sharesdeed of 28-12-2023
- 10 sharesdeed of 28-12-2023
Recent changes
Incorporation
Founding capital of €4,000, 100 shares · Founder: · Appointment: (director) · published on 28-12-2023 · Gazette deed
2 establishments registered
Watermael-Boitsfort and Zaventem
Official details
Source: KBO- Status
- Active since 22-12-2023Normal situation
- Activity
- “L'exercice,en son nom et pour son compte,de la médecine,et ce,par ses organes médecins légalement…” (deed in French)From the articles, 10 activitiesNo NACE code in the KBO yet
- Establishment units
- 2.354.532.7651170 Watermael-Boitsfort, since 22-12-2023
- 2.354.533.0621930 Zaventem, since 22-12-2023
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Annual accounts 2025
- €52,749▼ 8.0%
- €23,795▼ 14.4%
- €42,251▲ 26.3%
- €84,607▼ 18.7%
- Filing
- Filed on 14-07-2026, 17 days before the end of the filing period
Insights on DOCSTEPH
DOCSTEPH files the micro format. That format states no turnover. The gross margin rose from €13,161 in 2023 to €52,749 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 14-07-2026, 17 days before the deadline€52,749
▼ 8.0%
€32,007
▼ 13.4%
€23,795
▼ 14.4%
-€22,654
▲ €27,596
49.9%
▲ 17.8 percentage points
0.47
▲ 0.18
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €160,000. Estimated: probably between €100,000 and €270,000.
Balance sheet
balance sheet total €84,607 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet: assets | ||||
20/58 |
84,607 | 104,129 | 113,633 | |
21/28 |
64,905 | 83,706 | 103,813 | |
21 |
58,758 | 71,833 | 84,909 | |
22/27 |
6,147 | 11,873 | 18,904 | |
24 |
6,147 | 11,873 | 18,904 | |
29/58 |
19,702 | 20,423 | 9,820 | |
40/41 |
- | 0 | 4,930 | |
40 |
- | 0 | 4,930 | |
54/58 |
5,568 | 4,632 | 4,000 | |
490/1 |
14,134 | 15,791 | 890 | |
| Balance sheet: equity and liabilities | ||||
10/49 |
84,607 | 104,129 | 113,633 | |
10/15 |
42,251 | 33,456 | 5,671 | |
10/11 |
4,000 | 4,000 | 4,000 | |
14 |
38,251 | 29,456 | 1,671 | |
17/49 |
42,356 | 70,673 | 107,962 | |
42/48 |
42,356 | 70,673 | 107,962 | |
42 |
- | 17,775 | 17,775 | |
44 |
7,915 | 16,145 | 52,817 | |
440/4 |
7,915 | 16,145 | 52,817 | |
45 |
7,946 | 18,323 | 16,717 | |
450/3 |
7,946 | 2,823 | 9,217 | |
454/9 |
- | 15,500 | 7,500 | |
47/48 |
26,495 | 18,430 | 20,653 | |
| Income statement | ||||
9900 |
52,749 | 57,320 | 13,161 | |
630 |
20,489 | 20,107 | 9,941 | |
640/8 |
253 | 244 | 232 | |
9901 |
32,007 | 36,969 | 2,988 | |
65/66B |
267 | 361 | 100 | |
65 |
267 | 361 | 100 | |
9903 |
31,740 | 36,608 | 2,888 | |
67/77 |
7,946 | 8,823 | 1,217 | |
9904 |
23,795 | 27,785 | 1,671 | |
9905 |
23,795 | 27,785 | 1,671 | |
| Appropriation of the result | ||||
9906 |
53,251 | 29,456 | 1,671 | |
14P |
29,456 | 1,671 | - | |
694/7 |
15,000 | - | - | |
694 |
15,000 | - | - | |
| Document | ||||
The notes to these accounts have 9 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 14-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| 52,496 | 57,075 | 12,929 | ||
| 44,284 | 47,892 | 11,612 | ||
| 1,688 | 0 | 113,754 | ||
| 936 | 632 | - | ||
| -22,654 | -50,250 | -98,142 | ||
| 49.9% | 32.1% | 5.0% | ||
| 0.47 | 0.29 | 0.09 | ||
| 1.00 | 2.11 | 19.04 | ||
| 56.3% | 83.0% | 29.5% | ||
| 28.1% | 26.7% | 1.5% | ||
| over 100 | over 100 | over 100 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Tangible fixed assets | €1,688 | - | €22,254 |
| Intangible fixed assets | - | - | €91,500 |
| €20,489 | €20,107 | €9,941 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
Insights on DOCSTEPH
The operating result for 2025 is 13% lower than in 2024.
Debt's share of the balance-sheet total falls from 67.9% to 50.1%. Equity is higher and debt is lower.
Board & ownership
Board
1 director, since incorporationMandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), appointed by deed of 28-12-2023, still in office
Control
Founders
,
This company
DOCSTEPH
Equity €42,251
Profit €23,795 in 2025
Capital
- Contribution
- €4,000
- Shares
- 100
- Contribution per share
- €40
- Equity per share
- €423 in 2025
- Source
- deed of 28-12-2023
Articles of association
deed of 28-12-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- “Article 14. Contrôle de la société Lorsque la loi l'exige et dans les limites qu'elle prévoit, le contrôle de la société est assuré par un…”
Shareholders
At incorporation
deed of 28-12-2023 ↗
- 90 shares (90%) · €3,600
- 10 shares (10%) · €400
Network & group
No group
DOCSTEPH has no parent and no holdings in its annual accounts. is the only director. DOCSTEPH shares no director with another company.
Timeline
Timeline
6 events since 2023Filings
Financial
Establishments
2023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 17 days before the deadline
2025
Annual accounts 2024 filed PDFmicro format · 13 days late
2024
Highest result from 2023 to 2025 net €27,785 ▲1,563% The operating result of €36,969 and the net result of €27,785 are both a record.
Annual accounts 2023 filed PDFmicro format · 19 days late
2023
IncorporationFounding capital of €4,000, 100 shares · Founder: · Appointment: (director) · published on 28-12-20235 points ▸
- Founder,
- Founding capital, €4,000, 100 shares
- 100 shares
- Registered office clause, Watermael-Boitsfort (1170 Bruxelles), 47 avenue des Ortolans (rez-de-chaussée)
- Director appointment, (director (not named in the articles))
- The deed holds 4 more points.
2 establishments registered Watermael-Boitsfort and Zaventem
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Identity
- Enterprise number
- 1003.862.007
- VAT number
- BE 1003.862.007
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 22-12-2023
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- “Article 14. Contrôle de la société Lorsque la loi l'exige et dans les limites qu'elle prévoit, le contrôle de la société est assuré par un…”deed of 28-12-2023 (in French)
- Peppol
- Not found in the Peppol Directory
- Name
- DOCSTEPH in French
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 28-12-2023 (in French)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Région de Bruxelles-Capitale”deed of 28-12-2023 (in French)
Activities
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “L'exercice,en son nom et pour son compte,de la médecine,et ce,par ses organes médecins légalement habilités à pratiquer la médecine,en…”deed of 28-12-2023 (in French)
10 activities
- L'exercice,en son nom et pour son compte,de la médecine,et ce,par ses organes médecins légalement habilités à pratiquer la médecine,en Belgique ou à l'étranger,et qui apportent à la société la totalité ou une partie de leur activité médicale
- En cas de pluralité d'associés,ceux-ci mettent en commun la totalité de leur activité médicale au sein de la société
- Les honoraires sont perçus par et pour la société
- Toute exploitation commerciale de la médecine
- Toutes formes de collusion directe ou indirecte,de dichotomie ou de surconsommation
- Tout développement d'une quelconque activité commerciale
- Pratiquer une médecine de qualité par l'amélioration et la rationalisation de l'équipement professionnel notamment en assurant la gestion d'un cabinet médical,en ce compris l'acquisition,la location et l'entretien du matériel médical et des biens d'équipement,la facturation,et la perception d'honoraires médicaux,la mise à disposition de tout ce qui est nécessaire à l'exercice de l'art de guérir
- Exécuter toutes opérations généralement quelconques,commerciales,industrielles,financières,mobilières et immobilières se rapportant directement ou indirectement à son objet en Europe et dans le monde
- Louer ou sous-louer,acquérir des droits réels ou la pleine propriété de tout immeuble dans le but soit d'y établir son siège social,un siège d'exploitation ou d'y loger son dirigeant et les membres de sa famille à titre de résidence principale ou secondaire
- La gestion et la valorisation d'un patrimoine immobilier,avec ou sans lien direct avec l'activité médicale,en pleine propriété ou en droits réels,notamment par l'achat,la vente,la location,la mise en location,la construction,le tout au sens le plus large,pour autant que n'en soit altéré son caractère civil
Registered office and establishments
2 establishments| Establishment | Since | Unit number |
|---|---|---|
| Ortolanenlaan 47 registered office 1170 Watermael-Boitsfort 86210 General medical practice | 22-12-2023 | 2.354.532.765 |
| de Selliersstraat 19 1930 Zaventem 86210 General medical practice | 22-12-2023 | 2.354.533.062 |
Buildings and parcels at the addresses
- Ground area
- 909 m²
- Buildings
- 207 m²
- Volume, LiDAR
- 1,519 m³
- Tallest building
- 13.3 m
Buildings to scale, each on its own parcel
Parcels
Flanders
1
(50%)
Brussels
1
(50%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21017D0355/00P006 | Brussels | 555 m² | 1 · 82 m² | 13.3 m · 4 |
| 23094D0203/00R039 | Flanders | 354 m² | 1 · 125 m² | 10.7 m · 1 |
Contact
E-mail
etien.s@gmail.com